Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Harnessing the Electronic Health Record to Distribute Transition Services to Adolescents With Inflammatory Bowel Disease.

Huang JS, Yueh R, Wood K, Ma S, Cruz R, Boyd N, Kruth R, Parker J.

J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):200-204. doi: 10.1097/MPG.0000000000002516.

PMID:
31978017
2.

Harnessing the Electronic Health Record to Distribute Transition Services to Adolescents With Inflammatory Bowel Disease.

Huang JS, Yueh R, Wood K, Ma S, Cruz R, Boyd N, Kruth R, Parker J.

J Pediatr Gastroenterol Nutr. 2019 Oct 1. doi: 10.1097/MPG.0000000000002516. [Epub ahead of print]

PMID:
31577652
3.

Public servant, silent servant: A call to action for advocacy training in public service settings.

Hunt MG, Miller RA, Stacy MA, Lynam S, Carr ER.

Psychol Serv. 2019 Aug 19. doi: 10.1037/ser0000387. [Epub ahead of print]

PMID:
31424240
4.

Adolescents' and Young Adults' Satisfaction with and Understanding of Medical Notes from a Pediatric Gastroenterology Practice: A Cross-Sectional Cohort Study.

Huang JS, Yueh R, Ma S, Cruz R, Bauman L, Choi LJ.

J Pediatr. 2019 Dec;215:264-266. doi: 10.1016/j.jpeds.2019.06.052. Epub 2019 Jul 31.

PMID:
31377044
5.

Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury.

Duarte S, Matian P, Ma S, Busuttil RW, Coito AJ.

Am J Pathol. 2018 Aug;188(8):1820-1832. doi: 10.1016/j.ajpath.2018.05.002. Epub 2018 Jun 2.

6.

The association of recovery orientation and stigmatizing beliefs.

Stacy MA, Rosenheck R.

J Ment Health. 2019 Jun;28(3):276-281. doi: 10.1080/09638237.2017.1417573. Epub 2017 Dec 22.

PMID:
29271673
7.

Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study.

Goetz CG, Stebbins GT, Chung KA, Nicholas AP, Hauser RA, Merkitch D, Stacy MA.

Mov Disord. 2017 Sep;32(9):1335-1336. doi: 10.1002/mds.27092. Epub 2017 Jun 24. No abstract available.

PMID:
28646494
8.

Dopamine Transporter Imaging has no Impact on Functional Outcomes in de Novo Probable Parkinson's Disease.

Hickey PT, Kuchibhatla M, Scott B, Gauger L, Stacy MA.

J Parkinsons Dis. 2017;7(2):279-287. doi: 10.3233/JPD-160937.

PMID:
28339403
9.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
10.

Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.

Parkinson Study Group SURE-PD Investigators, Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, Hooper DC, Kieburtz KD, Macklin EA, Oakes D, Rudolph A, Shoulson I, Tennis MK, Espay AJ, Gartner M, Hung A, Bwala G, Lenehan R, Encarnacion E, Ainslie M, Castillo R, Togasaki D, Barles G, Friedman JH, Niles L, Carter JH, Murray M, Goetz CG, Jaglin J, Ahmed A, Russell DS, Cotto C, Goudreau JL, Russell D, Parashos SA, Ede P, Saint-Hilaire MH, Thomas CA, James R, Stacy MA, Johnson J, Gauger L, Antonelle de Marcaida J, Thurlow S, Isaacson SH, Carvajal L, Rao J, Cook M, Hope-Porche C, McClurg L, Grasso DL, Logan R, Orme C, Ross T, Brocht AF, Constantinescu R, Sharma S, Venuto C, Weber J, Eaton K.

JAMA Neurol. 2014 Feb;71(2):141-50. doi: 10.1001/jamaneurol.2013.5528.

11.

Which dyskinesia scale best detects treatment response?

Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy MA, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S.

Mov Disord. 2013 Mar;28(3):341-6. doi: 10.1002/mds.25321. Epub 2013 Feb 6.

PMID:
23390076
12.

Research management team (RMT): a model for research support services at Duke University.

Snyder DC, Epps S, Beresford HF, Ennis C, Levens JS, Woody SK, Tcheng JE, Stacy MA, Nahm M.

Clin Transl Sci. 2012 Dec;5(6):464-9. doi: 10.1111/cts.12010.

13.

ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia.

Brashear A, Mink JW, Hill DF, Boggs N, McCall WV, Stacy MA, Snively B, Light LS, Sweadner KJ, Ozelius LJ, Morrison L.

Dev Med Child Neurol. 2012 Nov;54(11):1065-7. doi: 10.1111/j.1469-8749.2012.04421.x. Epub 2012 Aug 28. Review.

14.

Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy.

Stacy MA, Murck H, Kroenke K.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):57-61. doi: 10.1016/j.pnpbp.2009.09.023. Epub 2009 Sep 28.

PMID:
19793544
15.

What's in the pipeline for the treatment of Parkinson's disease?

Sommer DB, Stacy MA.

Expert Rev Neurother. 2008 Dec;8(12):1829-39. doi: 10.1586/14737175.8.12.1829. Review.

PMID:
19086879
16.

Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome.

Kuncel AM, Turner DA, Ozelius LJ, Greene PE, Grill WM, Stacy MA.

Clin Neurol Neurosurg. 2009 Apr;111(3):303-6. doi: 10.1016/j.clineuro.2008.10.015. Epub 2008 Dec 10.

17.

Pesticide exposure and risk of Parkinson's disease: a family-based case-control study.

Hancock DB, Martin ER, Mayhew GM, Stajich JM, Jewett R, Stacy MA, Scott BL, Vance JM, Scott WK.

BMC Neurol. 2008 Mar 28;8:6. doi: 10.1186/1471-2377-8-6.

18.

Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.

Kulkarni AS, Balkrishnan R, Anderson RT, Edin HM, Kirsch J, Stacy MA.

Mov Disord. 2008 Feb 15;23(3):359-65.

PMID:
18074366
19.

The sensitivity and specificity of the 9-item Wearing-off Questionnaire.

Stacy MA, Murphy JM, Greeley DR, Stewart RM, Murck H, Meng X; COMPASS-I Study Investigators.

Parkinsonism Relat Disord. 2008;14(3):205-12. Epub 2007 Sep 27.

PMID:
17900967
20.

Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.

Hancock DB, Martin ER, Stajich JM, Jewett R, Stacy MA, Scott BL, Vance JM, Scott WK.

Arch Neurol. 2007 Apr;64(4):576-80.

PMID:
17420321
21.

Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.

Pahwa R, Stacy MA, Factor SA, Lyons KE, Stocchi F, Hersh BP, Elmer LW, Truong DD, Earl NL; EASE-PD Adjunct Study Investigators.

Neurology. 2007 Apr 3;68(14):1108-15.

PMID:
17404192
22.

Skin rash associated with Sinemet does not equal levodopa allergy.

Chou KL, Stacy MA.

Neurology. 2007 Mar 27;68(13):1078-9. No abstract available.

PMID:
17389317
23.

Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor.

Stacy MA, Elble RJ, Ondo WG, Wu SC, Hulihan J; TRS study group.

Mov Disord. 2007 Apr 30;22(6):833-8.

PMID:
17343274
24.

NOS2A and the modulating effect of cigarette smoking in Parkinson's disease.

Hancock DB, Martin ER, Fujiwara K, Stacy MA, Scott BL, Stajich JM, Jewett R, Li YJ, Hauser MA, Vance JM, Scott WK.

Ann Neurol. 2006 Sep;60(3):366-73.

PMID:
16823855
25.

Topiramate in essential tremor: a double-blind, placebo-controlled trial.

Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, Koller WC, Schwarzman L, Wu SC, Hulihan JF; Topiramate Essential Tremor Study Investigators.

Neurology. 2006 Mar 14;66(5):672-7. Epub 2006 Jan 25.

PMID:
16436648
26.

Family-based case-control study of cigarette smoking and Parkinson disease.

Scott WK, Zhang F, Stajich JM, Scott BL, Stacy MA, Vance JM.

Neurology. 2005 Feb 8;64(3):442-7.

PMID:
15699372
27.

Discrete and dynamic scaling of the size of continuous graphic movements of parkinsonian patients and elderly controls.

Longstaff MG, Mahant PR, Stacy MA, Van Gemmert AW, Leis BC, Stelmach GE.

J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):299-304.

28.

Physiology and pathophysiology of cortico-basal ganglia-thalamocortical loops: theoretical and practical aspects.

Baev KV, Greene KA, Marciano FF, Samanta JE, Shetter AG, Smith KA, Stacy MA, Spetzler RF.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):771-804. Review.

PMID:
12188109
29.

Movement disorders and normal aging.

Mahant PR, Stacy MA.

Neurol Clin. 2001 Aug;19(3):553-63, vi. Review.

PMID:
11532643
30.

Malignant catatonia secondary to sporadic encephalitis lethargica.

Shill HA, Stacy MA.

J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):402-3. No abstract available.

31.

Pain as a manifestation of seizure disorder.

Sahota PK, Stacy MA.

Clin Electroencephalogr. 1993 Apr;24(2):63-6.

PMID:
8500249

Supplemental Content

Loading ...
Support Center